GeneDx Holdings Corp [WGS] stock prices are up 9.91% to $161.08 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The WGS shares have gain 24.34% over the last week, with a monthly amount glided 24.99%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GeneDx Holdings Corp [NASDAQ: WGS] stock has seen the most recent analyst activity on October 20, 2025, when Canaccord Genuity initiated its Buy rating and assigned the stock a price target of $155. Previously, Piper Sandler started tracking the stock with Overweight rating on July 09, 2025, and set its price target to $110. On May 15, 2025, Guggenheim initiated with a Buy rating and assigned a price target of $88 on the stock. Jefferies upgraded its rating to a Buy but stick to its price target of $80 on May 09, 2025. Wells Fargo initiated its recommendation with a Equal Weight and recommended $34 as its price target on August 28, 2024. Craig Hallum started tracking with a Buy rating for this stock on July 10, 2024, and assigned it a price target of $43.
The stock price of GeneDx Holdings Corp [WGS] has been fluctuating between $55.17 and $147.71 over the past year. Currently, Wall Street analysts expect the stock to reach $153.75 within the next 12 months. GeneDx Holdings Corp [NASDAQ: WGS] shares were valued at $161.08 at the most recent close of the market. An investor can expect a potential drop of -4.55% based on the average WGS price forecast.
Analyzing the WGS fundamentals
The GeneDx Holdings Corp [NASDAQ:WGS] reported sales of 402.19M for trailing twelve months, representing a surge of 51.86%. Gross Profit Margin for this corporation currently stands at 0.7% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.01 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 151.03 points at the first support level, and at 140.98 for the second support level. However, for the 1st resistance point, the stock is sitting at 166.65, and for the 2nd resistance point, it is at 172.23.
Ratios To Look Out For
It’s worth pointing out that GeneDx Holdings Corp [NASDAQ:WGS]’s Current Ratio is 2.71. On the other hand, the Quick Ratio is 2.59, and the Cash Ratio is 1.1. Considering the valuation of this stock, the price to sales ratio is 11.58, the price to book ratio is 15.92 and price to earnings (TTM) ratio is 2671.31.
Transactions by insiders
Recent insider trading involved RUCH JOSHUA, Director, that happened on Nov 24 ’25 when 38000.0 shares were purchased. CHIEF EXECUTIVE OFFICER, Stueland Katherine completed a deal on Oct 29 ’25 to sell 2158.0 shares. Meanwhile, CHIEF FINANCIAL OFFICER Feeley Kevin sold 388.0 shares on Oct 29 ’25.
